CD46 and cancer: In tumor tissues, CD46 was most prevalently expressed in cancers of the colon and prostate, in which more than 35 % of the tumors overexpressed CD46, while CD46 expression was less than 11% in other tumors (Table 1 and Supplementary Figure S1).